Forte Biosciences (#$FBRX) Stock Hub: argenx Acquisition Completed at $77 Cash
www.merlintrader.com/forte-biosci...
Forte Biosciences (#$FBRX) Stock Hub: argenx Acquisition Completed at $77 Cash
www.merlintrader.com/forte-biosci...
Also keeping an eye on: $SDOT $FBRX $LASR
DDAmanda finds them early: https://DDAmanda.com/
Also keeping an eye on: $SDOT $FBRX $LASR
DDAmanda finds them early: https://DDAmanda.com/
Similar early alerts: $RNAZ $TDTH $FBRX
Find the next one: #pricinganda.com/#pricing" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">DDAmanda.com/#pricing
Similar early alerts: $RNAZ $TDTH $FBRX
Find the next one: #pricinganda.com/#pricing" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">DDAmanda.com/#pricing
Kornfeld Steven () reported special transactions (Non-P/S).
Kornfeld Steven () reported special transactions (Non-P/S).
Kapoor Shivpreet Singh () reported special transactions (Non-P/S).
Kapoor Shivpreet Singh () reported special transactions (Non-P/S).
GRYSKA DAVID W () reported special transactions (Non-P/S).
GRYSKA DAVID W () reported special transactions (Non-P/S).
FINCK BARBARA K () reported special transactions (Non-P/S).
FINCK BARBARA K () reported special transactions (Non-P/S).
Doberstein Stephen K () reported special transactions (Non-P/S).
Doberstein Stephen K () reported special transactions (Non-P/S).
Brun Scott C. () reported special transactions (Non-P/S).
Brun Scott C. () reported special transactions (Non-P/S).
VINCENT RICHARD G () reported special transactions (Non-P/S).
VINCENT RICHARD G () reported special transactions (Non-P/S).
Riley Antony A (CHIEF FINANCIAL OFFICER) reported special transactions (Non-P/S).
Riley Antony A (CHIEF FINANCIAL OFFICER) reported special transactions (Non-P/S).
Wagner Paul A. (SEE REMARKS) reported special transactions (Non-P/S).
Wagner Paul A. (SEE REMARKS) reported special transactions (Non-P/S).
Pursuant to the Merger Agreement, and upon the terms and subject to the conditions described therein and in the Offer to Purchase, dated August 6, 2026, and the related Letter of Transmittal, on August 6, 2026, Purchaser commenced a tender offer to purchase all of the Company’s issued and...
Pursuant to the Merger Agreement, and upon the terms and subject to the conditions described therein and in the Offer to Purchase, dated August 6, 2026, and the related Letter of Transmittal, on August 6, 2026, Purchaser commenced a tender offer to purchase all of the Company’s issued and...
Forte Biosciences, Inc. (FBRX) filed a Form 25-NSE with the SEC on August 27, 2026, notifying the delisting of its Common Stock from The Nasdaq Stock Market LLC.
🧵 continued ↓
Forte Biosciences, Inc. (FBRX) filed a Form 25-NSE with the SEC on August 27, 2026, notifying the delisting of its Common Stock from The Nasdaq Stock Market LLC.
🧵 continued ↓
Forte Biosciences, Inc. has been acquired by argenx BV through a tender offer and subsequent merger.
🧵 continued ↓
Forte Biosciences, Inc. has been acquired by argenx BV through a tender offer and subsequent merger.
🧵 continued ↓
⚠️ $FBRX Forte Biosciences/Delisting: Formal delisting from Nasdaq effective Aug 27, 2026—shares likely to become illiquid [HIGH RISK]
⚠️ $FBRX Forte Biosciences/Delisting: Formal delisting from Nasdaq effective Aug 27, 2026—shares likely to become illiquid [HIGH RISK]
• Quantity: 1.5M shares
• Price: $76.9
• Total: $115.35M
Large institutional order detected away from public markets.
Track more: stocknear.com/dark-pool-flow
• Quantity: 1.5M shares
• Price: $76.9
• Total: $115.35M
Large institutional order detected away from public markets.
Track more: stocknear.com/dark-pool-flow
Score 7/10 · Medium · 3 days
Score 7/10 · Medium · 3 days
Score 7/10 · Medium · 3 days
Score 7/10 · Medium · 3 days